Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting

By: Hemogenyx Pharmaceuticals PLC via AccessWire

June 25, 2021 at 11:15 AM EDT

LONDON, ENGLAND / ACCESSWIRE / June 25, 2021 / Hemogenyx Pharmaceuticals plc (OTC PINK:HOPHF) (LSE:HEMO) is pleased to announce that, at the Annual General Meeting ('AGM') held earlier today, all resolutions were duly passed. The numbers of votes for each resolution are presented below.

AGM Voting Results

Ordinary Resolutions	Votes for	% of votes cast for	Votes Against	% of votes cast against	Total votes cast	Total votes cast as % of ISC (1)	Votes with-held (2)
1. To adopt the 2020 Annual Report and Accounts	126,557,317	99.87%	168,193	0.13%	126,725,510	12.93%	289,150
2. To approve the Directors' Remuneration Policy	125,619,330	99.07%	1,177,033	0.93%	126,796,363	12.94%	218,297
3. To approve the Directors' Remuneration Report	125,638,477	99.07%	1,177,033	0.93%	126,815,510	12.94%	199,150
4. To reappoint the Company's auditor	126,528,170	99.87%	168,193	0.13%	126,696,363	12.93%	318,297
5. To authorise the Audit Committee to determine the auditor's remuneration	126,356,107	99.72%	350,256	0.28%	126,706,363	12.93%	308,297
6. To re-elect Sir Marc Feldmann as a director of the Company	125,895,121	99.28%	911,242	0.72%	126,806,363	12.94%	208,297
7. To authorise the Directors to allot equity securities	125,663,209	99.11%	1,133,154	0.89%	126,796,363	12.94%	218,297
Special Resolutions	Votes for	% of votes cast for	Votes against	% of votes cast against	Total votes cast	Total votes cast as % of ISC (1)	Votes with-held (2)
8. To disapply pre-emption provisions	123,047,368	97.04%	3,748,995	2.96%	126,796,363	12.94%	218,297
9. To adopt new Articles of Association	125,663,209	99.27%	923,154	0.73%	126,586,363	12.92%	428,297
10. To adopt new Articles of Association	126,014,268	99.36%	811,242	0.64%	126,825,510	12.94%	189,150

(1) The Company's issued share capital ('ISC') on 23 June 2021, being the date on which members had to be entered in the register of members of the Company in order to be entitled to attend and vote at the meeting, was 979,749,321 ordinary shares.

(2) A 'vote withheld' in respect of any resolution is not a vote in law and is not counted in the calculation of the proportion of the votes for and against it.

Enquiries:

Hemogenyx Pharmaceuticals plc
https://hemogenyx.com

Dr Vladislav Sandler, Chief Executive Officer & Co-Founder
headquarters@hemogenyx.com

Peter Redmond, Director
peter.redmond@hemogenyx.com

SP Angel Corporate Finance LLP
Tel: +44 (0)20 3470 0470
Matthew Johnson, Vadim Alexandre, Adam Cowl

Peterhouse Capital Limited
Tel: +44 (0)20 7469 0930
Lucy Williams, Duncan Vasey, Charles Goodfellow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Hemogenyx Pharmaceuticals PLC

View source version on accesswire.com:
https://www.accesswire.com/653122/Hemogenyx-Pharmaceuticals-PLC-Announces-Result-of-Annual-General-Meeting

Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting

More News

Recent Quotes